Kelvin Cooper, PhD

Executive Director Drug Development

Kelvin Cooper

Kelvin is a seasoned pharmaceutical scientist and executive with more than 45 years of experience in all aspects of drug discovery and development across several therapeutic areas including infectious disease, cancer, respiratory, immunology, and inflammation.

 

Before joining Lakewood-Amedex, Kelvin filled several roles at Pfizer from 1981 to 2011, including Senior Vice President for Portfolio Development in their Established Pharmaceutical Sciences Business Unit from 2009 to 2011; Senior Vice President of Worldwide Pharmaceutical Sciences with responsibility for both small molecules and biologics in the areas of drug substance, drug product, and device development from 2000 to 2008; Executive Director of drug development for cancer, respiratory, allergy, immunology, and infectious disease from 1998 to 2000; and Director of Drug Discovery in those same therapeutic areas 1994-1997.

 

Kelvin earned a Ph.D. in Organic Chemistry from the University of Nottingham and is a past recipient of the Captain Black Award for Science. He has also authored 49 publications and holds 34 patents.